Q & M Dental Group (Singapore) Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Q & M Dental Group (Singapore) de 5.6% y 4.1% por año respectivamente. Se prevé que el BPA crezca en un 0.9% al año. Se espera que la rentabilidad financiera sea de 14.6% en 3 años.

Información clave

5.6%

Tasa de crecimiento de los beneficios

0.9%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	18.7%
Tasa de crecimiento de los ingresos	4.1%
Rentabilidad financiera futura	14.6%
Cobertura de analistas	Low
Última actualización	23 Oct 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Q & M Dental Group (Singapore)'s (SGX:QC7) Returns On Capital Are Heading Higher

Nov 01

Investors Met With Slowing Returns on Capital At Q & M Dental Group (Singapore) (SGX:QC7)

Sep 29

Is Q & M Dental Group (Singapore) (SGX:QC7) Using Too Much Debt?

Aug 16

Is Q & M Dental Group (Singapore) (SGX:QC7) Using Too Much Debt?

Oct 18

Need To Know: Analysts Are Much More Bullish On Q & M Dental Group (Singapore) Limited (SGX:QC7) Revenues

May 16

Revenue Beat: Q & M Dental Group (Singapore) Limited Beat Analyst Estimates By 18%

May 13

Returns At Q & M Dental Group (Singapore) (SGX:QC7) Appear To Be Weighed Down

Mar 31

Chin-Siau Ng Is The Founder of Q & M Dental Group (Singapore) Limited (SGX:QC7) And They Just Sold 100% Of Their Shares

Mar 16

Does Q & M Dental Group (Singapore) (SGX:QC7) Have A Healthy Balance Sheet?

Mar 11

Can You Imagine How Q & M Dental Group (Singapore)'s (SGX:QC7) Shareholders Feel About The 28% Share Price Increase?

Feb 21

What Kind Of Shareholders Hold The Majority In Q & M Dental Group (Singapore) Limited's (SGX:QC7) Shares?

Jan 24

Is Weakness In Q & M Dental Group (Singapore) Limited (SGX:QC7) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Jan 05

Is Q & M Dental Group (Singapore) (SGX:QC7) Struggling?

Dec 18

We Think Q & M Dental Group (Singapore) (SGX:QC7) Can Stay On Top Of Its Debt

Dec 02

Previsiones de crecimiento de beneficios e ingresos

SGX:QC7 - Estimaciones futuras de los analistas y datos financieros pasados (SGD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	206	19	27	33	2
12/31/2025	195	18	26	35	3
12/31/2024	189	17	28	31	3
6/30/2024	184	16	31	36	N/A
3/31/2024	184	14	29	35	N/A
12/31/2023	183	12	27	33	N/A
9/30/2023	183	6	28	35	N/A
6/30/2023	177	7	22	30	N/A
3/31/2023	178	8	14	26	N/A
12/31/2022	181	11	23	34	N/A
9/30/2022	187	17	30	41	N/A
6/30/2022	202	23	45	57	N/A
3/31/2022	209	28	51	59	N/A
12/31/2021	206	30	42	51	N/A
9/30/2021	196	33	36	45	N/A
6/30/2021	177	29	32	38	N/A
3/31/2021	152	28	21	28	N/A
12/31/2020	138	20	16	24	N/A
9/30/2020	129	20	16	22	N/A
6/30/2020	121	18	8	15	N/A
3/31/2020	128	16	20	25	N/A
12/31/2019	128	18	21	28	N/A
9/30/2019	126	13	16	23	N/A
6/30/2019	124	13	12	18	N/A
3/31/2019	121	13	9	15	N/A
12/31/2018	121	14	10	13	N/A
9/30/2018	120	15	10	15	N/A
6/30/2018	120	15	11	16	N/A
3/31/2018	120	25	N/A	18	N/A
12/31/2017	123	24	N/A	17	N/A
9/30/2017	134	39	N/A	25	N/A
6/30/2017	144	38	N/A	22	N/A
3/31/2017	153	28	N/A	22	N/A
12/31/2016	155	28	N/A	19	N/A
9/30/2016	145	12	N/A	12	N/A
6/30/2016	137	12	N/A	13	N/A
3/31/2016	129	12	N/A	13	N/A
12/31/2015	124	11	N/A	13	N/A
9/30/2015	122	13	N/A	10	N/A
6/30/2015	120	12	N/A	13	N/A
3/31/2015	110	10	N/A	11	N/A
12/31/2014	100	9	N/A	11	N/A
9/30/2014	90	8	N/A	4	N/A
6/30/2014	80	7	N/A	3	N/A
3/31/2014	75	7	N/A	2	N/A
12/31/2013	71	6	N/A	4	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (5.6% al año) de QC7 es superior a la tasa de ahorro (2.2%).

Beneficios vs. Mercado: Se prevé que los beneficios (5.6% al año) de QC7 crezcan menos que el mercado SG (11.4% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de QC7 crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (4.1% al año) de QC7 crezcan más rápidamente que los del mercado SG (3.8% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 4.1% al año) de QC7 crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de QC7 sea baja dentro de 3 años (14.6%).

Q & M Dental Group (Singapore) Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target decreased by 11% to S$0.34

Consensus EPS estimates fall by 41%

Price target decreased by 12% to S$0.38

Consensus EPS estimates fall by 12%

Price target decreased to S$0.44

Consensus EPS estimates fall by 23%

Recent updates

Q & M Dental Group (Singapore) Limited (SGX:QC7) acquired Dental clinic business of Veritas Dental Pte. Ltd for SGD 0.80 million.

First half 2024 earnings released: EPS: S$0.01 (vs S$0.006 in 1H 2023)

First half dividend of S$0.004 announced

Q & M Dental Group (Singapore) Limited Appoints Chew Chong Yin as an Independent Non-Executive Director

Q & M Dental Group (Singapore) Limited Announces Changes of Director

Q & M Dental Group (Singapore) Limited Announces Resignation of Ang Ee Peng Raymond as Executive Director

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Q & M Dental Group (Singapore) Limited, Annual General Meeting, Apr 16, 2024

New minor risk - Financial position

Final dividend of S$0.0053 announced

Q & M Dental Group (Singapore) Limited Declares Second Interim Dividend for 2H2023, Payable on March 26, 2024

Full year 2023 earnings released: EPS: S$0.012 (vs S$0.012 in FY 2022)

Q & M Dental Group (Singapore)'s (SGX:QC7) Returns On Capital Are Heading Higher

Price target decreased by 11% to S$0.34

Consensus EPS estimates fall by 41%

First half 2023 earnings released: EPS: S$0.006 (vs S$0.01 in 1H 2022)

Price target decreased by 12% to S$0.38

Shanghai Zhibao Investment Consulting Co., Ltd. entered into a share transfer agreement to acquire 80% stake in Shanghai Chuangyi Investment Management Co., Ltd. from Shanghai Zhibao Investment Consulting Co., Ltd. for CNY 0.5 million.

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 12%

Full year 2022 earnings released: EPS: S$0.012 (vs S$0.032 in FY 2021)

Price target decreased to S$0.44

Third quarter 2022 earnings released: EPS: S$0.004 (vs S$0.01 in 3Q 2021)

Q & M Dental Group (Singapore) Limited Reports Plant and Equipment Written Off for the Third Quarter Ended September 30, 2022

Investors Met With Slowing Returns on Capital At Q & M Dental Group (Singapore) (SGX:QC7)

Consensus EPS estimates fall by 23%

Price target decreased to S$0.61

Is Q & M Dental Group (Singapore) (SGX:QC7) Using Too Much Debt?

Price target decreased to S$0.69

Second quarter 2022 earnings released: EPS: S$0.004 (vs S$0.009 in 2Q 2021)

Q & M Dental Group (Singapore) Limited Declares No Dividend for the Second Quarter Ended 30 June 2022

Q & M Dental Group (Singapore) Limited Announces Resignation of Lim Sim Ving as Company Secretary

Full year 2021 earnings: EPS and revenues miss analyst expectations

Q & M Dental Group (Singapore) Limited, Annual General Meeting, Apr 29, 2022

Upcoming dividend of S$0.01 per share

Q & M Dental Group (Singapore) Limited Announces Retirement of Sim Yu Xiong as Chief Financial Officer

Full year 2021 earnings: EPS and revenues miss analyst expectations

Founder recently bought S$2.3m worth of stock

Upcoming dividend of S$0.01 per share

Third quarter 2021 earnings released

Is Q & M Dental Group (Singapore) (SGX:QC7) Using Too Much Debt?

Alternate Director recently sold S$412k worth of stock

Consensus forecasts updated

Alternate Director recently sold S$66k worth of stock

Need To Know: Analysts Are Much More Bullish On Q & M Dental Group (Singapore) Limited (SGX:QC7) Revenues

Revenue Beat: Q & M Dental Group (Singapore) Limited Beat Analyst Estimates By 18%

Q & M Dental Group (Singapore) Limited Announces First Interim One Tier Tax Exempt Cash Dividend for the First Quarter Ended March 31, 2021, Payable on June 2, 2021

First quarter 2021 earnings released

Returns At Q & M Dental Group (Singapore) (SGX:QC7) Appear To Be Weighed Down

Price target increased to S$0.72

Chin-Siau Ng Is The Founder of Q & M Dental Group (Singapore) Limited (SGX:QC7) And They Just Sold 100% Of Their Shares

Does Q & M Dental Group (Singapore) (SGX:QC7) Have A Healthy Balance Sheet?

Full year 2020 earnings released

Revenue and earnings beat expectations

New 90-day high: S$0.60

Can You Imagine How Q & M Dental Group (Singapore)'s (SGX:QC7) Shareholders Feel About The 28% Share Price Increase?

New 90-day low: S$0.45

What Kind Of Shareholders Hold The Majority In Q & M Dental Group (Singapore) Limited's (SGX:QC7) Shares?

Is Weakness In Q & M Dental Group (Singapore) Limited (SGX:QC7) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Is Q & M Dental Group (Singapore) (SGX:QC7) Struggling?

We Think Q & M Dental Group (Singapore) (SGX:QC7) Can Stay On Top Of Its Debt

Earnings released

Q & M Dental Group (Singapore) Limited (SGX:QC7) completed the acquisition of a part of business from Acumen Research Laboratories Pte Ltd. for SGD 0.65 million.

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento